High-flow nasal cannula for Acute Respiratory Distress Syndrome (ARDS) due to COVID-19
Multidisciplinary Respiratory Medicine · 16.09.2020 · 15
DOI: 10.4081/mrm.2020.693 ↗Kurz gefasst
Fachartikel in der Zeitschrift Multidisciplinary Respiratory Medicine, online erschienen am 16.09.2020. Verfasst von Carolina Panadero und 22 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonology Department, Hospital Universitario de Getafe, Madrid. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
High-flow nasal cannula oxygen therapy (HFNC) has been shown to be a useful therapy in the treatment of patients with Acute Respiratory Distress Syndrome (ARDS), but its efficacy is still unknown in patients with COVID-19. Our objective is to describe its utility as therapy for the treatment of ARDS caused by SARS-CoV-2.
Methods
A retrospective, observational study was performed at a single centre, evaluating patients with ARDS secondary to COVID-19 treated with HFNC. The main outcome was the intubation rate at day 30, which defined failure of therapy. We also analysed the role of the ROX index to predict the need for intubation.
Results
In the study period, 196 patients with bilateral pneumonia were admitted to our pulmonology unit, 40 of whom were treated with HFNC due to the presence of ARDS. The intubation rate at day 30 was 52.5%, and overall mortality was 22.5%. After initiating HFNC, the SpO2/FiO2 ratio was significantly better in the group that did not require intubation (113.4±6.6 vs 93.7±6.7, p=0.020), as was the ROX index (5.0±1.6 vs 4.0±1.0, p=0.018). A ROX index less than 4.94 measured 2 to 6 h after the start of therapy was associated with increased risk of intubation (HR 4.03 [95% CI 1.18 – 13.7]; p=0.026).
Conclusion
High-flow therapy is a useful treatment in ARDS in order to avoid intubation or as a bridge therapy, and no increased mortality was observed secondary to the delay in intubation. After initiating HFNC, a ROX index below 4.94 predicts the need for intubation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pulmonology Department, Hospital Universitario de Getafe, Madrid.
- Department of Pediatrics, Hospital Universitario de Getafe, Madrid.
- Thoracic Surgery Department, Hospital Universitario de Getafe, Madrid.
- Cardiology Department, Hospital Universitario de Getafe, Madrid.
- Cardiology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CIBERCV, Madrid, Spain.
Zitieren
APA
Panadero, C., Abad-Fernández, A., Rio-Ramirez, M. T., Acosta Gutierrez, C. M., Calderon-Alcala, M., Lopez-Riolobos, C., Matesanz-Lopez, C., Garcia-Prieto, F., Diaz-Garcia, J. M., Raboso-Moreno, B., Vasquez-Gambasica, Z., Andres-Ruzafa, P., Garcia-Satue, J. L., Calero-Pardo, S., Sagastizabal, B., Bautista, D., Campos, A., González, M., Grande, L., …, & Alcaraz, A. J. (2020). High-flow nasal cannula for Acute Respiratory Distress Syndrome (ARDS) due to COVID-19. Multidisciplinary Respiratory Medicine, 15. https://doi.org/10.4081/mrm.2020.693
Vancouver
Panadero C, Abad-Fernández A, Rio-Ramirez MT, Acosta Gutierrez CM, Calderon-Alcala M, Lopez-Riolobos C, et al. High-flow nasal cannula for Acute Respiratory Distress Syndrome (ARDS) due to COVID-19. Multidisciplinary Respiratory Medicine. 2020;15. doi:10.4081/mrm.2020.693
BibTeX
@article{Panadero2020,
author = {Panadero, Carolina and Abad-Fernández, Araceli and Rio-Ramirez, Mª Teresa and Acosta Gutierrez, Carmen Maria and Calderon-Alcala, Mariara and Lopez-Riolobos, Cristina and Matesanz-Lopez, Cristina and Garcia-Prieto, Fernando and Diaz-Garcia, Jose Maria and Raboso-Moreno, Beatriz and Vasquez-Gambasica, Zully and Andres-Ruzafa, Pilar and Garcia-Satue, Jose Luis and Calero-Pardo, Sara and Sagastizabal, Belen and Bautista, Diego and Campos, Alfonso and González, Marina and Grande, Luis and Jimenez Fernandez, Marta and Santiago-Ruiz, Jose L and Caravaca Perez, Pedro and Alcaraz, Andres Jose},
title = {High-flow nasal cannula for Acute Respiratory Distress Syndrome (ARDS) due to COVID-19},
journal = {Multidisciplinary Respiratory Medicine},
year = {2020},
volume = {15},
doi = {10.4081/mrm.2020.693}
}
EUVIMED